Beryl Drugs board approves director re-appointments, sets AGM agenda

Beryl Drugs Limited's board of directors met on Tuesday, September 2nd, 2025, approving several significant matters. The board approved its report, fixed the date and notice for the 32nd annual general meeting (AGM), and set the annual book closure dates. Additionally, the cut-off date and remote e-voting period for the ensuing AGM were finalized.

The board also made key appointments, with Dipika Kataria named as scrutinizer for the remote e-voting and voting at the 32nd AGM. Furthermore, Sanjay Sethi was re-appointed as the managing director for a five-year term, subject to shareholder approval. Dipika Kataria was also appointed as the practicing company secretary for a five-year term (2025-2030) as secretarial auditor, also subject to shareholder approval.

Finally, the directors of Beryl Drugs Limited were authorized to authenticate and file forms under the Companies Act, 2013, on behalf of the company.